rs142617606
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_206933.4(USH2A):c.11734G>A(p.Glu3912Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E3912E) has been classified as Benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | c.11734G>A | p.Glu3912Lys | missense_variant | Exon 61 of 72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000683 AC: 17AN: 248720 AF XY: 0.0000742 show subpopulations
GnomAD4 exome AF: 0.000114 AC: 166AN: 1461830Hom.: 0 Cov.: 33 AF XY: 0.0000908 AC XY: 66AN XY: 727214 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000151 AC: 23AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74362 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified Uncertain:1
The p.Glu3912Lys variant in USH2A has not been previously reported in individual s with hearing loss, but has been identified in 20/124246 European chromosomes b y the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbS NP rs142617606). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational pr ediction tools and conservation analyses do not provide strong support for or ag ainst an impact to the protein. In summary, the clinical significance of the p.G lu3912Lys variant is uncertain. -
Inborn genetic diseases Uncertain:1
The c.11734G>A (p.E3912K) alteration is located in exon 61 (coding exon 60) of the USH2A gene. This alteration results from a G to A substitution at nucleotide position 11734, causing the glutamic acid (E) at amino acid position 3912 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Usher syndrome type 2A Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at